Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 3/20 | 0.46 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.46 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.46 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.46 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.46 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.46 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.46 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.36 |
| ▸ | PHLPP2 | Q6ZVD8 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18773697 | 0.90 | GAA (0.39) | CHRM1CHRM2CHRM3CHRM4CHRM5 | |
| SCHEMBL19273357 | 0.81 | — | — | |
| SCHEMBL13875466 | 0.81 | CHRM1 (0.44) | CHRM1CHRM2CHRM3CHRM4CHRM5 | |
| SCHEMBL19101661 | 0.80 | CHRM1 (0.47) | CHRM1CHRM2CHRM3CHRM4CHRM5 | |
| SCHEMBL24056618 | 0.79 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL12549371 | 0.79 | HCAR2 (0.34) | CHRM1LMNAALDH1A1KDM4E | |
| SCHEMBL9054542 | 0.79 | TSHR (0.33) | ALDH1A1 | |
| SCHEMBL15468449 | 0.78 | TSHR (0.35) | CA12CA1CA2CA9 | |
| SCHEMBL20925310 | 0.78 | — | — | |
| SCHEMBL10066324 | 0.78 | TSHR (0.35) | CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11860540-B2 | Positive resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-01-02 | — | — | US | disclosed |
| US-20210364921-A1 | POSITIVE RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-11-25 | — | — | US | disclosed |
| US-20210356879-A1 | PLANOGRAPHIC PRINTING PLATE PRECURSOR, METHOD OF PREPARING PLANOGRAPHIC PRINTING PLATE, AND PLANOGRAPHIC PRINTING METHOD | FUJIFILM CORPORATION (JP) | 2021-11-18 | — | — | US | disclosed |
| EP-3473678-A1 | RESIN COMPOSITION AND USE THEREOF | Sumitomo Chemical Company Limited (JP) | 2019-04-24 | — | — | EP | disclosed |
| US-8188204-B2 | Polymers, compositions and methods for use for foams, laundry detergents, shower rinses and coagulants | RHODIA INC. (US) | 2012-05-29 | — | — | US | disclosed |
| US-20110257015-A1 | POLYMERS, COMPOSITIONS AND METHODS FOR USE FOR FOAMS, LAUNDRY DETERGENTS, SHOWER RINSES AND COAGULANTS | RHODIA INC. (US) | 2011-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110257015-A1 | POLYMERS, COMPOSITIONS AND METHODS FOR USE FOR FOAMS, LAUNDRY DETERGENTS, SHOWER RINSES AND COAGULANTS | DSG1, DSTN, TES | CHRM1 3996/4885CHRM2 3383/4885CHRM3 3408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.